{"title":"Research Progress on the Safety of Bromocriptine in Prolactinoma Patients during Pregnancy and Lactation","authors":"奉公 李","doi":"10.12677/wjcr.2023.134020","DOIUrl":null,"url":null,"abstract":"Bromocriptine is widely used in pituitary prolactinoma and is the oral drug of choice. However,","PeriodicalId":496807,"journal":{"name":"Shi jie zhong liu yan jiu","volume":"40 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Shi jie zhong liu yan jiu","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12677/wjcr.2023.134020","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Bromocriptine is widely used in pituitary prolactinoma and is the oral drug of choice. However,
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
